Eliem Therapeutics (Uk) Ltd
11893311
Some Concerns
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 19/03/2026
Due 02/04/2027
Industry
Officers
Persons with Significant Control
Climb Bio Inc.
Corporation Service Company, 251 Little Falls Drive, Wilmington, 19808
Reg: 7108886 · Delaware Secretary Of State · Corporation
Notified 21/08/2021
Former PSCs
Andrew David Levin
Ceased 18/12/2019
Mrs Valerie Daniele Morisset
Ceased 01/10/2021
CompanyRankvs 763+ SIC 72110 peers61
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
compensation charge. The company continues to evaluate its pre-clinical Kv7 programme, including seeking a partner for future development. Further, the directors believe that the company remains a going concern due to the continued financial backing of the parent undertaking and the absence of any material uncertainties that would cast doubt on the company’s ability to continue operating for th
Key FinancialsYear ending 31/12/2024
Net Worth
£80k
Balance sheet strength
Cash
£50k
Cash in the bank
Net Current Assets
£80k
Working capital
Current Assets
£161k
Current Liabilities
£81k
Debtors
£112k
Profit After Tax
-£13.1M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 1.99 | -£11.1M |
| 2023 | 2.97 | -£14.6M |
| 2022 | 5.75 | +£6.9M |
| 2021 | 3.33 | +£3.8M |
| 2020 | 8.21 | — |
Derived from filed accounts. Not audited figures.